Skip to main content

Table 1 Baseline characteristics (N = 523,811)

From: Prescription of potentially inappropriate medication in Korean older adults based on 2012 Beers Criteria: a cross-sectional population based study

Characteristics

 

Male (n = 212,082) No (%)

 

Female (n = 311,729) No (%)

 

Total (n = 523,811) No (%)

Age, years

      

 65–69

85,169

(40.16)

101,098

(32.43)

186,267

(35.56)

 70–74

62,964

(29.69)

85,631

(27.47)

148,595

(28.37)

 75–79

37,059

(17.47)

62,664

(20.10)

99,723

(19.04)

 80–84

17,559

(8.28)

38,087

(12.22)

55,646

(10.62)

 ≥85

9,331

(4.40)

24,249

(7.78)

33,580

(6.41)

No. of medications prescribed

      

 0–5

83,104

(39.18)

99,179

(31.82)

182,283

(34.80)

 6–9

106,319

(50.13)

169,554

(54.39)

275,873

(52.67)

 ≥10

22,659

(10.68)

42,996

(13.79)

65,655

(12.53)

No. of medications from Beers Criteria 2012

      

 0

45,721

(21.56)

54,026

(17.33)

99,747

(19.04)

 1–4

155,456

(73.30)

237,099

(76.06)

392,555

(74.94)

 ≥5

10,905

(5.14)

20,604

(6.61)

31,509

(6.02)

Visited specialtya

      

Physicianb

99,893

(54.14)

138,452

(51.48)

238,345

(52.56)

Surgeonc

56,601

(30.68)

72,949

(27.12)

129,550

(28.57)

Othersd

28,014

(15.18)

57,548

(21.40)

85,562

(18.87)

Types of healthcare facilitiesa

      

Long-term care

2,928

(1.58)

6,518

(2.41)

9,446

(2.08)

Primary care

129,480

(69.98)

200,631

(74.33)

330,111

(72.56)

Secondary care

13,695

(7.40)

20,414

(7.56)

34,109

(7.50)

Tertiary care

38,923

(21.04)

42,342

(15.69)

81,265

(17.86)

Residential areaa

      

 Urban

94,571

(44.60)

131,528

(42.21)

226,099

(43.17)

 Rural

117,488

(55.40)

180,104

(57.79)

297,628

(56.83)

Type of insurance

      

 National Health Insurance

197,538

(93.14)

276,179

(88.60)

473,717

(90.44)

 Medical Aid, Veteran’s Relief

14,544

(6.86)

35,550

(11.40)

50,094

(9.56)

No. of OPDe visits within one year

      

 0 or 1

191,787

(90.43)

285,795

(91.68)

477,582

(91.17)

 2–4

12,254

(5.78)

14,580

(4.68)

26,834

(5.12)

 ≥5

8,041

(3.79)

11,354

(3.64)

19,395

(3.70)

Comorbidities

      

 Hypertension

126,438

(59.62)

209,452

(67.19)

335,890

(64.12)

 Diabetes mellitus

71,857

(33.88)

104,600

(33.55)

176,457

(33.69)

 Hyperlipidemia

71,736

(33.82)

123,920

(39.75)

195,656

(37.35)

 Cardiovascular disease (MIf or angina)

31,599

(14.90)

42,366

(13.59)

73,965

(14.12)

 Heart failure

22,570

(10.64)

43,549

(13.97)

66,119

(12.62)

 Dementia and cognitive impairment

17,334

(8.17)

36,658

(11.76)

53,992

(10.31)

 Cerebrovascular disease (TIAg)

45,832

(21.61)

69,881

(22.42)

115,713

(22.09)

 Peripheral artery disease (PADi)

38,829

(18.31)

65,826

(21.12)

104,655

(19.98)

 Chronic kidney disease

6,664

(3.14)

5,847

(1.88)

12,511

(2.39)

 Liver cirrhosis

51,766

(24.41)

67,601

(21.69)

119,367

(22.79)

 Chronic lung disease (asthma, COPDh)

75,575

(35.63)

105,636

(33.89)

181,211

(34.59)

 Cancer

39,935

(18.83)

38,203

(12.26)

78,138

(14.92)

 Depression

19,635

(9.26)

42,375

(13.59)

62,010

(11.84)

Charlson Comorbidity Index

      

 0–1

83,991

(39.60)

122,379

(39.26)

206,370

(39.40)

 2–4

81,114

(38.25)

129,131

(41.42)

210,245

(40.14)

 ≥5

46,977

(22.15)

60,219

(19.32)

107,196

(20.46)

  1. aMissing data were excluded. Percentages (%) were calculated after excluding the missing data; bIncludes: emergency medicine, family medicine, general medicine, internal medicine, neurology, occupational & environmental medicine, pediatrics, psychiatry, rehabilitation medicine, and tuberculosis department; cIncludes: cardiothoracic surgery, dermatology, general surgery, neurosurgery, orthopedics, otorhinolaryngology, and urology; dIncludes: anesthesiology, dentistry, laboratory medicine, nuclear medicine, oriental medicine, pathology, preventive medicine, radiology, and radiation oncology; eOPD outpatient department; fMI, myocardial infarction; gTIA, transient ischemic attack; hCOPD, chronic obstructive pulmonary disease; iPAD, peripheral artery disease